Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy

Table 1

Relationships between clinicopathological parameters and NLR and PLR.

Variable	NLR < 4.1	NLR ≥ 4.1	value	PLR < 164.7	PLR ≥ 164.7	value
Age			0.043			0.146
Mean	65.57	68.52		65.89	68.07
Median (range)	65 (29–87)	69 (32–87)		65 (29–87)	69 (32–87)
Gender			0.216			0.513
Male	123	70		130	63
Female	23	7		22	8
CCI score	2.65 ± 0.88	2.68 ± 0.98	0.85	2.51 ± 0.88	2.60 ± 0.99	0.485
T			0.835			0.537
Tis, Ta, T1	57	31		61	27
T2	33	14		34	13
T3	29	16		31	14
T4	25	16		24	17
Tx	2	0		2	0
N			0.34			0.095
N0	120	59		125	54
N1-3	21	15		20	16
Nx	5	3		7	1
Grade			0.929			0.072
Low	8	4		11	1
High	138	73		141	70
LVI			0.333			0.892
Present	43	18		42	19
Absent	103	59		110	52
CIS			0.069			0.32
Present	10	1		6	5
Absent	136	76		146	66
Adjuvant chemotherapy			0.806			0.554
Present	19	11		19	11
Absent	126	66		132	60
Hydronephrosis			0.284			0.054
Present	34	23		33	24
Absent	112	54		119	47

CCI: Charlson Comorbidity index; LVI: lymphovascular invasion; CIS: carcinoma in situ; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio.